| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.8 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.0081 | 0.8 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.8 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.8 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.0075 | 0.8 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | -0.009 | 0.8 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.8 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |